Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Next week should be very interesting !

<< Previous

Bullboard Posts

Next >>

Comment by stephanedodieron Nov 17, 2020 10:39am

111 Views

Post# 31913980

RE:Next week should be very interesting !

I think you are right, just one week delay. There is one 70K unusual trade this morning. Maybe a director, but anyway, I feel that we might see the $3cnd land again.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Sept. 19, 2024